PTMS, CPTAC-1532 - CPTAC Assay Portal
- ️ABCC's Scientific Web Programming Group, Frederick National Laboratory for Cancer Research (FNLCR)
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.
Assay Details for CPTAC-1533 Collapse assay details
Data source: Panorama
-
Official Gene Symbol
- PTMS Peptide Sequence
- AAEEEDEADPKR Modification Type
- unmodified Protein - Site of Modification
- N/A Peptide - Site of Modification
- N/A Peptide Start
- 82 Peptide End
- 93
-
CPTAC ID
- CPTAC-1533 Peptide Molecular Mass
- 1,358.5950 Species
- Homo sapiens (Human) Assay Type
- Direct MRM or SRM Matrix
- Ovarian cancer tumor tissue lysate Submitting Laboratory
- Pacific Northwest National Laboratory Submitting Lab PI
- Tao Liu
Assay Parameters Collapse assay parameters
Data source: Panorama
-
Instrument
- TSQ Vantage Internal Standard
- peptide Peptide Standard Purity
- >95% Peptide Standard Label Type
- 13C and 15N at C-terminus R
-
LC
- Waters nanoACQUITY (Part Number 176016000) Column Packing
- Waters BEH C18, 1.7 um 130 Å (Part Number 186007485) Column Dimensions
- 100 um x 100 mm Flow Rate
- 0.4 uL/min
Assay Multiplexing Expand assay panel
Pacific Northwest National Laboratory-DirectSRM1
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
| Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
| y8 (2+) | 16.4 | 7.8 | 12.4 | 38.9 | 14.3 | 14.3 | 42.2 | 16.3 | 18.9 | 15 | 15 | 15 |
| y9 (2+) | 9.6 | 15.1 | 10.1 | 32.1 | 27.9 | 12.5 | 33.5 | 31.7 | 16.1 | 15 | 15 | 15 |
| y10 (2+) | 7.1 | 6.9 | 4.3 | 26.1 | 18.3 | 13.7 | 27 | 19.6 | 14.4 | 15 | 15 | 15 |
| sum | 6.9 | 6 | 3.9 | 27.8 | 18 | 12.3 | 28.6 | 19 | 12.9 | 15 | 15 | 15 |
Additional Resources and Comments
Assay Details for CPTAC-1532 Collapse assay details
Data source: Panorama
-
Official Gene Symbol
- PTMS Peptide Sequence
- SVEAAAELSAK Modification Type
- unmodified Protein - Site of Modification
- N/A Peptide - Site of Modification
- N/A Peptide Start
- 5 Peptide End
- 15
-
CPTAC ID
- CPTAC-1532 Peptide Molecular Mass
- 1,074.5557 Species
- Homo sapiens (Human) Assay Type
- Direct MRM or SRM Matrix
- Ovarian cancer tumor tissue lysate Submitting Laboratory
- Pacific Northwest National Laboratory Submitting Lab PI
- Tao Liu
Assay Parameters Collapse assay parameters
Data source: Panorama
-
Instrument
- TSQ Vantage Internal Standard
- peptide Peptide Standard Purity
- >95% Peptide Standard Label Type
- 13C and 15N at C-terminus K
-
LC
- Waters nanoACQUITY (Part Number 176016000) Column Packing
- Waters BEH C18, 1.7 um 130 Å (Part Number 186007485) Column Dimensions
- 100 um x 100 mm Flow Rate
- 0.4 uL/min
Assay Multiplexing Expand assay panel
Pacific Northwest National Laboratory-DirectSRM1
Chromatograms
Data source: Panorama
Response Curves
Data source: Panorama
Retrieving Data
Repeatability
Data source: Panorama
| Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
| y7 (1+) | 18.1 | 4.4 | 6.8 | 54 | 37.8 | 40.1 | 57 | 38.1 | 40.7 | 15 | 15 | 15 |
| y8 (1+) | 14.7 | 8.8 | 3 | 53.4 | 36.3 | 37.5 | 55.4 | 37.4 | 37.6 | 15 | 15 | 15 |
| y9 (1+) | 4.8 | 4 | 3 | 63 | 36.6 | 37.4 | 63.2 | 36.8 | 37.5 | 15 | 15 | 15 |
| sum | 4.5 | 3.1 | 3 | 57.6 | 36.5 | 37.8 | 57.8 | 36.6 | 37.9 | 15 | 15 | 15 |